News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
almirall
Lebrikizumab maintains skin clearance over one year in atopic dermatitis monotherapy trials
Healthcare
Almirall recently announced topline results from one-year analyses of the efficacy and safety of…
adntro team
ADNTRO Genetics, a Spanish start-up with a multidisciplinary team involved in the bioinformatics analysis
Healthcare
The analysis focuses on genomic data provided by various genomic technologies
bcn
BCN HEALTH presents three communications in the congress ILC assessing clinical and economic burden of patients with HDV coinfection and HBV monoinfection in Spain
Healthcare · Corporate
BCN HEALTH presents the poster "Increased baseline comorbidity burden including liver severity…
asabys
Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M
Corporate
Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners…
plg
The occasion of the VCoE Members' Meeting
Healthcare · Corporate
The Venture Centre of Excellence, a public-private co-investment programme of EIT Health and the…
3p
3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial
Healthcare · Biosimilars · Industrial biotechnology
Mucormycosis is a difficult to treat invasive fungal infection with high mortality
ana polanco
Spanish biotechnology sector breaks record figures for six years in a row, according to AseBio 2021 Report
Corporate
The AseBio 2021 Report was presented at ICEX in Madrid on Thursday, with the support of Merck,…
bti
BTI leads the scientific production of Spanish bio-companies for the seventh consecutive year
Access to innovation · Corporate
This is the seventh consecutive year that the Vitoria-based biotech company has been ranked number…
oryzon
ORYZON announces a New Financing through a Convertible Bond Program for a Total amount up to €20 Million over 30 months
Corporate
Funding provided by Nice & Green SA, a Swiss institutional investor